Results 141 to 150 of about 38,283 (218)

Anellovirus-mediated interferon dysregulation enhances virus-induced lung injury. [PDF]

Am J Respir Cell Mol Biol
Banday MM, Banday S, Rahman M, Harrison AO, Singh N, Moore RM, Khan MM, Shankar S, Goda Y, Coppolino A, Movval N, Stutts S, Woolley A, Dishaw L, Goldberg H, Mebratu Y, Polson SW, Patel KN, Gaggar A, Hayes D, Krishnamoorthy N, Gewurz BE, Washko G, Tesfaigzi Y, Rehman R, Sharma NS.   +25 more
europepmc   +1 more source

Strain Matching of Seasonal Influenza Vaccines and Emergence of Neuraminidase Inhibitor Resistance in China from 2015 to 2025. [PDF]

Vaccines (Basel)
He P, Luo J, Pu S, Cui S, Zhu H, Zhu W, Gao R.   +6 more
europepmc   +1 more source

Epidemiological, Clinical and Viral Genomic Features of Influenza Virus Infections Among Pilgrims During the Grand Magal of Touba Over 7 Years (2018-2024). [PDF]

J Med Virol
Diouf C, Diallo S, Ouaddane I, Ndiaye D, Goumballa N, Fam D, Beye M, Mauguin C, Bossi V, Andreani J, Bassene H, Colson P, Gautret P, Sokhna C.   +13 more
europepmc   +1 more source

Influenza A/H3N2 epidemiology in England during the 2025 to 2026 season: a mathematical modelling study. [PDF]

Commun Health
Hay JA, Alahakoon P, Greenshields-Watson A, Kendall M, Ghafari M, Wymant C, Hinch R, Ferretti L, Panovska-Griffiths J, Fraser C.   +9 more
europepmc   +1 more source

Evaluation of Immunogenicity and Cross-Protective Efficacy of a CpG-Adjuvanted Trivalent Inactivated Influenza Vaccine in Ferrets. [PDF]

Vaccines (Basel)
Qiu Y, Zhang Y, He S, Wang Y, Wang R, Han Y, He W, Sho E, Han S, Wu H.   +9 more
europepmc   +1 more source

Emergence and Genomic Characterisation of Influenza Virus A(H3N2) Subclade K in Saudi Arabia: Dominant Circulation With Fixed HA1 Substitutions and High-Frequency HA-NA Clade Association, 2025-2026. [PDF]

J Med Virol
Naeem A, Hakami M, Alanazi KM, Alzahrani N, Bosaeed M.   +4 more
europepmc   +1 more source

Natural infection and vaccination with influenza A (H3N2).

, 1977
Previous assessments of the efficacy of inactivated influenza A vaccines have met with only limited success. Low challenge rates, lack of a stable population and inadequate information on vaccine and control groups have made results difficult to interpret.
openaire   +1 more source

Mapping Sub-National Respiratory Virus Circulation in Cambodia Using Metatranscriptomic Sequencing: A Multi-Center Hospital-Based Surveillance Study. [PDF]

Influenza Other Respir Viruses
Yek C, Sebastian J, Chea S, Lay S, Oum M, Long L, Chea S, Pacheco AR, Barochia M, Ly P, Ly S, Sath R, Parker DM, Minin VM, Chung M, Ghedin E, Oliveira F, Manning JE, Lean K, Ny C, Long V, Leang K, Yim V, Hok K, Leang R, Huy R, Chin S, Chau D, Seng H, Ly S, Lon C.   +30 more
europepmc   +1 more source

Detection and characterization of antiviral-resistant viruses during the influenza season of 2024-25. [PDF]

Microbiol Spectr
Patel MC, Nguyen HT, Pascua PNQ, Lopez-Esteva M, Champion C, Mishin VP, Di H, Lacek K, Kirby MK, Bateman A, Sullivan M, Trow S, Laplante J, St George K, Rambo-Martin B, Merced-Morales A, Budd A, Kondor RJ, Davis CT, Gubareva LV.   +19 more
europepmc   +1 more source

The roles of pre-season immunity, age, viral shedding, and community exposures in shaping influenza household transmission dynamics. [PDF]

Nat Commun
Sauter MK, Kleynhans J, Moyes J, McMorrow ML, Treurnicht FK, Hellferscee O, von Gottberg A, Wolter N, Buys A, Maake L, Martinson NA, Kahn K, Lebina L, Motlhaoleng K, Wafawanaka F, Gómez-Olivé FX, Tempia S, Grenfell B, Viboud C, Sun K, Cohen C.   +20 more
europepmc   +1 more source